Comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers: The telemedical pilot project for integrative stroke care in Bavaria/Germany

Stroke

Volumn 37, Issue 7, 2006, Pages 1822-1827

  Audebert, Heinrich J ^a   Kukla, Christian ^a   Vatankhah, Bijan ^b   Gotzler, Berthold ^a   Schenkel, Johannes ^a   Hofer, Stephan ^c   Fürst, Andrea ^b   Haberl, Roman L ^a  

^a Munich Municipal Hospital   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Klinikum Freising   (Germany)

Author keywords

Stroke; Telemedicine; Thrombolysis

Indexed keywords

ALTEPLASE; ANTIHYPERTENSIVE AGENT; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CLINICAL PROTOCOL; COMMUNITY HOSPITAL; COMPARATIVE STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HEALTH CENTER; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTPATIENT DEPARTMENT; PATIENT CARE; PRIORITY JOURNAL; STROKE; STROKE PATIENT; TELECONSULTATION; TELEMEDICINE; TRANSIENT ISCHEMIC ATTACK; BRAIN ISCHEMIA; CASE MANAGEMENT; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER NETWORK; EVALUATION; FIBRINOLYTIC THERAPY; GERMANY; HOSPITAL DEPARTMENT; HYPERTENSION; INTERNAL MEDICINE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PATIENT TRANSPORT; PILOT STUDY; PROSPECTIVE STUDY; RADIOGRAPHY; RESIDENTIAL CARE; STATISTICS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BRAIN ISCHEMIA; CASE MANAGEMENT; CATCHMENT AREA (HEALTH); CEREBRAL HEMORRHAGE; COMPUTER COMMUNICATION NETWORKS; FEMALE; FIBRINOLYTIC AGENTS; GERMANY; HOSPITAL DEPARTMENTS; HOSPITALS, COMMUNITY; HUMANS; HYPERTENSION; INTERNAL MEDICINE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT TRANSFER; PILOT PROJECTS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REMOTE CONSULTATION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33745934529     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000226741.20629.b2     Document Type: Article

References (30)

1. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K, Heidrich J, Hermanek P, Leffmann C, Sitzer M, Biegler M, Buecker-Nott HJ, Berger K; German Stroke Registers Study Group. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. J Am Med Assoc. 2004;292:1831-1838.
2. Toni D, Chamorro A, Kaste M, Lees K, Wahlgren NG, Hacke W. Acute treatment of ischemic stroke. European Stroke Initiative. Cerebrovasc Dis. 2004;17(suppl 2):30-46.
3. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. J Am Med Assoc. 2000;283:1151-1158.
4. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;32:1832-1840.
5. Johnston SC, Fung LH, Gillum LA, Smith WS, Brass LM, Lichtman JH, Brown AN. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke. 2001;32:1061-1068.
6. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke. 2000;31:77-81.
7. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003;34:1106-1113.
8. Caplan LR. Treatment of acute stroke: still struggling. J Am Med Assoc. 2004;292:1883-1885.
9. Schwamm LH, Rosenthal ES, Hirshberg A, Schaefer PW, Little EA, Kvedar JC, Petkovska I, Koroshetz WJ, Levine SR. Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med. 2004;11:1193-1197.
10. Audebert HJ, Kukla C, Clarmann vC, Kuhn J, Vatankhah B, Schenkel J, Ickenstein GW, Haberl RL, Horn M. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke. 2005;36:287-291.
11. Audebert HJ, Wimmer ML, Schenkel J, Ulm K, Kolominsky-Rabas PL, Bogdahn U, Horn M, Haberl RL. Telemedicine stroke department network. Introduction of a telemedicine pilot project for integrated stroke management in South Bavaria and analysis of its efficiency (in German). Nervenarzt. 2004;75:161-165.
12. Ickenstein GW, Horn M, Schenkel J, Vatankhah B, Bogdahn U, Haberl R, Audebert HJ. The use of telemedicine in combination with a new stroke-code-box significantly increases t-PA use in rural communities. Neurocrit Care. 2005;3:27-32.
13. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774.
14. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ; Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056 -1083.
15. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119 -2125.
16. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, Ringleb AP, Lorenzano S, Manelfe C, Bozzao L. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999;30:2280-2284.
17. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
18. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke. 2003;34:2847-2850.
19. Koennecke HC, Nohr R, Leistner S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke. 2001;32:1074-1078.
20. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. J Am Med Assoc. 2000;283:1145-1150.
21. Grotta JC, Burgin WS, El Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexandrov AV. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol. 2001;58:2009-2013.
22. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005;172:1307-1312.
23. Schenkel J, Weimar C, Knoll T, Haberl RL, Busse O, Hamann GF, Koennecke HC, Diener HC. R1-systemic thrombolysis in German stroke units-the experience from the German Stroke data bank. J Neurol. 2003;250:320-324.
24. Bravata DM, Kim N, Concato J, Krumholz HM, Brass LM. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med. 2002;162:1994-2001.
25. Buchan AM, Barber PA, Newcommon N, Karbalai HG, Demchuk AM, Hoyte KM, Klein GM, Feasby TE. Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Neurology. 2000;54:679-684.
26. Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurru C, Biller J. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke. 2001;32:12-16.
27. Akins PT, Delemos C, Wentworth D, Byer J, Schorer SJ, Atkinson RP. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? Neurology. 2000;55:1801-1805.
28. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). J Am Med Assoc. 1995;274:1017-1025.
29. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.
30. Grond M, Stenzel C, Schmulling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss WD. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke. 1998;29:1544-1549.